Drug Abuse in the parturient

Seminars in Anesthesia

Volumn 19, Issue 3, 2000, Pages 216-224

  Kuczkowski, Krzysztof M ^a,b   Birnbach, David J ^a,b   van Zundert, Andre ^a,b  

^a College of Physicians and Surgeons of Columbia University ^*  (United States)

^b CATHARINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; COCAINE; DIPHENHYDRAMINE; DOXEPIN; GLYCERYL TRINITRATE; HALOTHANE; HYDRALAZINE; ISOFLURANE; LABETALOL; OPIATE DERIVATIVE; SOLVENT; TOLUENE;

ALCOHOL CONSUMPTION; ANESTHESIA INDUCTION; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CORONARY ARTERY CONSTRICTION; DRUG CONTRAINDICATION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EUPHORIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INFANT WELFARE; INFECTION RISK; MATERNAL WELFARE; MEDICAL DECISION MAKING; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; REVIEW; SUBSTANCE ABUSE; TREATMENT PLANNING; VIRUS TRANSMISSION;

EID: 0033794735     PISSN: 02770326     EISSN: None     Source Type: Journal    
DOI: 10.1053/sa.2000.9041     Document Type: Article

References (133)

1. Recognizing illicit drug use in pregnant women: Reports from Oregon birth attendants
2. Characteristics of pregnant substance abusers in two cities in the northeast
3. Drug and alcohol use in the former Soviet Union: Selected factors and future considerations
4. Cocaine use in pregnancy in Amsterdam
5. Cocaine during pregnancy: A critical review of the literature
6. The prevalence of cocaine abuse during pregnancy in Barcelona
7. Editorial AIDS: The focus turns to women
8. Human immunodeficiency virus (HIV) disease: AIDS and related disorders
9. Prevalence of use of cocaine and other substances in an obstetric population
10. Substance abuse patterns in pregnant women
11. The relationship between recent cocaine use and pregnancy outcome
12. Predictors of cocaine use in pregnancy
13. Pharmacology and therapeutic applications of cocaine
14. Crack cocaine and cocaine hydrochloride: Are the differences myth or reality?
15. On the general effects of cocaine(1885)
16. Cocaine abuse: Neurochemistry, phenomenology and treatment
17. Anatomic actions of cocaine
18. Substance abuse and HIV in pregnancy
19. Cocaine abuse: Neurochemistry, phenomenology and treatment
20. The effects of acute and chronic cocaine use on the heart
21. Pregnancy increases cardiovascular toxicity of cocaine
22. Cardiovascular effects of cocaine during pregnancy
23. Anaesthesia management of a parturient with myocardial infarction related to cocaine use
24. Mechanisms responsible for the cardiotoxic effects of cocaine
25. Cocaine, catecholamines and cardiac toxicity
26. Mechanism of cocaine-induced myocardial depression in dogs
27. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission
28. Substance abuse in pregnancy: Symposium on women's healthcare
29. Cocaine intoxication presenting as preeclampsia and eclampsia
30. Cocaine abusing parturients undergoing cesarean section: A cohort study
31. Cocaine screening of parturients without prenatal care: An evaluation of a rapid screening assay
32. Cocaine disposition in the meconium from newborns of cocaine-abusing mothers and urine of adult drug users
33. Cocaine use during pregnancy: Sensitive detection by hair assay
34. Cocaine exposure during pregnancy: Improving assessment with radioimmunoassay of maternal hair
35. Transfer of cocaine by the perfused human placenta: The effect of binding to serum proteins
36. Maternal, placental and fetal pathophysiology of cocaine exposure during pregnancy
37. Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus
38. Cocaine abuse is associated with abruptio placentae and decreased birth weight, but not shorter labor
39. Cocaine use during pregnancy: Adverse perinatal outcome
40. Uterine rupture in association with alkaloidal cocaine use
41. Cocaine: How dangerous is it during pregnancy?
42. Uterine rupture associated with recent antepartum cocaine abuse
43. Cocaine-associated rhabdomyolysis causing renal failure in pregnancy
44. Hepatic rupture in pregnancy associated with cocaine use
45. Center for Disease Control: Urogenital anomalies in the offspring of women using cocaine during early pregnancy
46. Cocaine abuse in the parturient: What are the anesthetic implications?
47. Detection of multiple drug use in high risk patients using a new screening assay
48. Cocaine, dopamine and the endogenous opioid system
49. Hydralazine does not restore uterine blood flow during cocaine-induced hypertension in the pregnant ewe
50. Cocaine induced hypertension in the ewe and response to treatment with labetalol
51. The management of cocaine-associated myocardial ischemia
52. Cocaine toxicity and the calcium channel blockers nifedipine and nimodipine in rats
53. Cardiovascular disease in the pregnant patient: A new risk factor
54. Cocaine toxicity and isoflurane anesthesia: Hemodynamic, myocardial metabolic, and regional blood flow effects in swine
55. Hypertension and pulmonary oedema associated with ketamine administration in a patient with a history of substance abuse
56. Cocaine and succinylcholine sensitivity: A new caution
57. Nitroglycerine in the treatment of cocaine associated chest pain-clinical safety and efficacy
58. Development of a therapeutic vaccine for the treatment of cocaine addiction
59. Efficacy of a therapeutic cocaine vaccine in rodent models
60. A potential vaccine for cocaine abuse prophylaxis
61. Ecstasy and the dance with death
62. Hazards to health: Dextroamphetamine poisoning
63. Amphetamine ingestion presenting as eclampsia
64. Methamphetamine-related stroke: Four cases
65. Fetal and infant deaths associated with maternal methamphetamine abuse
66. Substance abuse in pregnancy: A bigger problem than you think
67. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (ecstasy)
68. Prenatal exposure to amphetaMines: Risks and adverse outcomes in pregnancy
69. The influence of amphetamine addiction on pregnancy and the newborn infant
70. Amphetamine ingestion with biliary atresia
71. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus
72. The impact of prenatal drug exposure on the neonate
73. Acute amphetamine abuse: Problems during general anesthesia for neurosurgery
74. Alteration of anesthetic requirement by amphetamine
75. Cardiac arrest in a chronic amphetamine abuser
76. Maternal and fetal effects of heroin addiction during pregnancy
77. Narcotic use in pregnancy
78. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission
79. Drug dependence and pregnancy: Antenatal and intrapartum problems
80. Acute abstinence syndrome after epidural injection of butorphanol
81. Fetal complications of maternal heroin addiction: Abnormal growth, infections and episodes of stress
82. Perinatal and neonatal issues of substance abuse
83. Clonidine in acute opiate withdrawal
84. Anesthesia and substance abuse
85. Epidural spinal infection in intravenous drug abusers
86. Parturients infected with human immunodeficiency virus and regional anesthesia: Clinical and immunologic response
87. Early penetration of the blood-brain barrier by HIV
88. Neuropathology of AIDS
89. Solvent sniffing: Physiological effects and community control measures
90. Equilibrium disorders with diffuse brain atrophy in long-term toluene sniffing
91. Toluene sniffing produces cerebellar degeneration. Am J
92. Changes in autonomic function as determined by ECG P-R interval vailability in sandal, shoe and leather workers exposed to n-hexane, xylene and toluene
93. Myocardial infarction and primary ventricular fibrillation after glue sniffing
94. Pulmonary function abnormalities in intentional spray paint inhalation
95. Glue-sniffing and distal renal tubular acidosis: Sticking to the facts
96. Toluene abuse during pregnancy: Obstetric complications and perinatal outcomes
97. Inhalant abuse in pregnancy
98. Toluene embryopathy: Two new cases
99. Toluene embryopathy
100. Equilibrium disorders with diffuse brain atrophy in long-term toluene sniffing
101. Smoking habits among pregnant women in Norway 1994-1995
102. Substance abuse and HIV in pregnancy
103. Smoking and drinking behavior before and during pregnancy of married mothers of live-born infants and stillborn infants
104. Metabolites of a tobacco-specific carcinogen in urine from newborns
105. Smoking, pregnancy, and the fetus
106. Oxygen and carbon monoxide equilibria of human adult hemoglobin at atmospheric and elevated pressure
107. Substance abuse in pregnancy
108. Cocaine and cigarettes: A comparison of risks
109. Effects of smoking during pregnancy
110. The influence of maternal passive and light active smoking on intrauterine growth and body composition of the newborn
111. The effects of cigarette smoking on the human placenta: A light and electron microscopic study
112. Effect of age, parity and smoking on pregnancy outcome: A population based study
113. Sudden infant death syndrome and smoking in the United States and Sweden
114. Socioeconomic status and maternal cigarette smoking before, during and after a pregnancy
115. Nicotine replacement therapy during pregnancy
116. Recent advances in the pharmacotherapy of smoking
117. Efficacy of bupropion for smoking cessation in nondepressed smokers
118. A controlled trial of sustained release bupropion and nicotine patch or both for smoking cessation
119. Smoking and anesthesia: Preoperative abstinence and perioperative morbidity
120. Alcohol consumption by pregnant women in the United States during 1988-1995
121. Les enfants de parents alcolques: Anomalies observees - A propos de 127 cases
122. Alcohol use in pregnancy
123. Council on Scientific Affairs, American Medical Association: Fetal effects of maternal alcohol abuse
124. Optic nerve hypoplasia in fetal alcohol syndrome: An update
125. Alcohol, astroglia and brain development
126. Effect of the social environment on alcohol involvement and subjective well-being prior to alcoholism treatment
127. Chronic alcohol intake does not change thiopental anesthetic requirement, pharmacokinetics, or pharmacodynamics